Lb Pharmaceuticals LBRX
NASDAQ LBRX
$39.23 -1.77 (-4.32%)
At close: Oct 21, 2026 · 4:00 PM EDT

Lb Pharmaceuticals (LBRX) Current Assets (2024 - 2026)

Updated

Lb Pharmaceuticals (LBRX) reported Current Assets of $355.3 million for Q2 2026, down 8.7% from the prior quarter.

Analysis

Lb Pharmaceuticals (LBRX) Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Lb Pharmaceuticals posted Current Assets of $308.43 million, up 968.0% from FY2024.

  • By year, Current Assets came in at $28.88 million in FY2024.
  • Five-year quarterly Current Assets spans a low of $28.88 million in Q4 2024 and a high of $389.07 million in Q1 2026.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $389.07 million (Q1 2026), $308.43 million (Q4 2025) and $316.4 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 64.67 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 59.77 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 33.67 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 36.68 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 27.35 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 27.97 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.96 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 13.95 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 41.36 Bn
10 Lb Pharmaceuticals 1.18 Bn -123.53 Mn - 355.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 355.30 Mn
Mar 31, 2026 389.07 Mn
Dec 31, 2025 308.43 Mn
Sep 30, 2025 316.40 Mn
Dec 31, 2024 28.88 Mn
API Access

Lb Pharmaceuticals Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=LBRX&period=max&api_key=YOUR_API_KEY